Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

ClinicalTrials.gov ID: NCT00268957

Public ClinicalTrials.gov record NCT00268957. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 1:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Parallel, Open-Label Study to Compare Once Per Day Sevelamer Carbonate Powder Dosing With Three Times Per Day Sevelamer Hydrochloride Tablet Dosing in Chronic Kidney Disease Patients on Hemodialysis

Study identification

NCT ID
NCT00268957
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genzyme, a Sanofi Company
Industry
Enrollment
217 participants

Conditions and interventions

Interventions

  • Sevelamer carbonate (Renvela®) Drug
  • Sevelamer hydrochloride (Renagel®) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Feb 28, 2007
Completion
Apr 30, 2007
Last update posted
Mar 18, 2014

2006 – 2007

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
29
Facility City State ZIP Site status
Clinical Research Center Birmingham Alabama 35213
Gadsden Dialysis Gadsden Alabama 35901
Holy Cross Renal Care Mission Hills California 91345
Nephrology Educational Services and Research Tarzana California 91356
Crystal Rivers Dialysis Center Crystal River Florida 34429
Outcomes Research International, Inc. Hudson Florida 34667
Central Dialysis Center Atlanta Georgia 30329
Atlanta Nephrology Referral Center Decatur Georgia 30030
FMC Marietta Marietta Georgia 30066
Horizon Healthcare Associates Flossmoor Illinois 60422
Indiana University Hospital Indianapolis Indiana 46202
Ochsner Clinic Foundation, Nephrology Research New Orleans Louisiana 70121
Henry Ford Hospital Detroit Michigan 48202
Southwest Mississippi Nephrology, PLLC Brookhaven Mississippi 39601
Nephrology Associates, P.C. Columbus Mississippi 39705
Nephrology & Hypertension Associates, LTD Tupelo Mississippi 38801
Washington University School of Medicine St Louis Missouri 63110
Hypertension and Nephrology Associates Eatontown New Jersey 07724
Winthrop University Dialysis Center Mineola New York 11501
Davita The Bronx New York 10461
Kidney and Hypertension Center Cincinnati Ohio 45220
Renal Care Group Cleveland Ohio 44109
Lewiston Dialysis Center Lewistown Pennsylvania 17044
Medical Nephrology Associates Dyersburg Tennessee 38024
Nephrology Associates, P.C. Nashville Tennessee 37205
Renal Research Inc. at the Kidney Institute Houston Texas 77054
Gambro Healthcare - Charlottesville Charlottesville Virginia 22902
Clinical Research of Tidewater Norfolk Virginia 23507
Virginia Commonwealth University, Division of Nephrology Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00268957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2014 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00268957 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →